Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 4:52 pm Purchase | 2026-03-02 | 13D | Akari Therapeutics, Plc AKTX | Ray Prudo, M.D. | 8,391,326,467 8.900% | 3,464,725,667 (+70.33%) | Filing History |
| 2026-03-04 4:44 pm Purchase | 2026-03-02 | 13D | Akari Therapeutics, Plc AKTX | Samir R. Patel | 9,725,215,000 10.400% | 9,725,215,000 (New Position) | Filing History |
| 2026-03-04 4:44 pm Purchase | 2026-03-02 | 13G | Akari Therapeutics, Plc AKTX | Hoyoung Huh, M.D., Ph.D. | 18,199,697,667 18.400% | 9,905,189,667 (+119.42%) | Filing History |
| 2025-02-14 5:00 pm Purchase | 2024-11-14 | 13G | Akari Therapeutics, Plc AKTX | Hoyoung Huh, M.D., Ph.D. | 8,294,508,000 15.500% | 8,294,508,000 (New Position) | Filing History |
| 2025-02-14 5:00 pm Purchase | 2024-11-14 | 13D | Akari Therapeutics, Plc AKTX | Ray Prudo, M.D. | 4,926,600,800 9.300% | 4,926,600,800 (New Position) | Filing History |
| 2024-12-06 4:00 pm Unchanged | 2024-12-06 | 13D | Akari Therapeutics, Plc AKTX | Samir R. Patel | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-06-20 07:30 am Unchanged | 2024-06-20 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-06-18 4:15 pm Unchanged | 2024-06-18 | 13D | Akari Therapeutics, Plc AKTX | Theofilos Charles Steve | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-06-07 6:00 pm Unchanged | 2024-06-07 | 13D | Akari Therapeutics, Plc AKTX | Samir R. Patel | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-04 12:34 pm Unchanged | 2024-01-04 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-10-20 5:00 pm Unchanged | 2023-10-20 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-14 4:06 pm Unchanged | 2023-04-14 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:05 pm Unchanged | 2023-02-14 | 13G | Akari Therapeutics, Plc AKTX | Samir R. Patel | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 08:02 am Unchanged | 2022-02-14 | 13G | Akari Therapeutics, Plc AKTX | Samir R. Patel | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-14 4:18 pm Unchanged | 2022-01-14 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-10-18 5:06 pm Unchanged | 2021-10-18 | 13D | Akari Therapeutics, Plc AKTX | RPC Pharma Ltd | 0 0.000% | 0 (Unchanged) | Filing |